You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol

Article metrics

Article menu

Download PDFPDF

XML
Oncology
Protocol
Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol

 

Online download statistics by month:

Online download statistics by month: May 2019 to June 2025

AbstractFullPdf
May 2019397391102
Jun 2019979427
Jul 2019646112
Aug 201955547
Oct 201954537
Nov 201924229
Dec 2019343111
Jan 2020292316
Feb 2020353210
Mar 202016166
May 202014147
Jun 2020282812
Jul 202019196
Aug 2020151412
Sep 202020206
Oct 2020282612
Nov 202011114
Dec 202018145
Jan 2021231616
Feb 2021161511
Mar 2021161610
Apr 202111102
May 2021131210
Jun 202116184
Jul 202123249
Aug 2021131116
Sep 202123215
Oct 2021302923
Nov 2021151310
Dec 202124223
Jan 202226246
Feb 202223209
Mar 2022161410
Apr 202215147
May 2022191412
Jun 202220217
Jul 202220146
Aug 202214146
Sep 2022998
Oct 202218137
Nov 2022221613
Dec 202214126
Jan 202319168
Feb 202318144
Mar 202316142
Apr 20231094
May 2023778
Jun 2023771
Jul 2023675
Aug 202313126
Sep 2023760
Oct 202323244
Nov 20239109
Dec 202318184
Jan 2024992
Feb 202417174
Mar 202417165
Apr 2024121311
May 202433268
Jun 2024252723
Jul 2024272127
Aug 2024192813
Sep 2024151511
Oct 2024774
Nov 202411104
Dec 202415157
Jan 2025424216
Feb 202555556
Mar 2025151510
Apr 2025232216
May 202514148
Jun 2025771
Total19131818718